On This Page
The health risk information presented here is summarized from Shoreland Travax®, a decision-support tool used by health care providers to perform a detailed health risk analysis based on specific locations, individual travel styles, and traveler risk behaviors. Travax provides practitioners current, independently researched malaria risk and prevention recommendations in a map-based format that goes beyond the annual WHO and US CDC statements included here. Not included here are current reports from Travax of disease outbreaks or environmental events that may pose elevated risks to travelers’ health and safety. The Providers section of this site offers a directory of health care providers who utilize Shoreland Travax for travel health counseling. Learn more about the detailed reports and maps available from these practitioners (includes links to samples).
See also: COVID-19 Traveler Summary
Fully vaccinated: 36.0%
Boosted or Additional Dose: 2.3%
Daily new cases: 14 (7-day rolling average)
Daily new cases / 100,000: 0.1
Daily new deaths: < 1 (7-day rolling average)
Daily new deaths / 100,000: 0.001
Guinea is a developing nation classified as low income. Located in western Africa along the Atlantic Ocean (north of Sierra Leone and south of Senegal), the climate classifications range from humid equatorial (short dry season) to dry (semi arid).
See also: Library article for Yellow Fever
An official yellow fever vaccination certificate may be required depending on your itinerary. Vaccination is usually recommended if you’ll be traveling in areas where there is risk of yellow fever transmission.
- Requirement: A certificate proving yellow fever vaccination is required for travelers aged ≥ 9 months coming from countries with risk of YF transmission. This does not apply to airport transit stops (no exit through immigration checkpoint) in risk countries. Note: Guinea requires proof of YF vaccination for all travelers entering through Ahmed Sékou Touré International Airport in Conakry, contrary to the requirements published in WHO's 2022 online update of International Travel and Health (ITH). This requirement will gradually be applied to other priority entry points during 2023.
- Official Status: listed by WHO as a country where YF transmission risk is present.
Depending on your itinerary, your personal risk factors, and the length of your visit, your health care provider may offer you vaccination against Ebola virus disease, hepatitis A, hepatitis B, influenza, measles, mumps, rubella, meningococcal meningitis, rabies, or typhoid fever. Routine immunizations, such as those that prevent tetanus/diphtheria or "childhood" diseases, should be reviewed and updated as needed.
See also: Library article for Malaria
The following is current information as reported by the World Health Organization (WHO) and the US Centers for Disease Control (CDC):
WHO—International Travel and Health (current online update, Country List)Malaria risk due predominantly to P. falciparum exists throughout the year in the entire country.
- Recommended prevention: C – Risk of P. falciparum malaria, in combination with reported chloroquine and sulfadoxine–pyrimethamine resistance. Mosquito bite prevention plus atovaquone–proguanil or doxycycline or mefloquine chemoprophylaxis (select according to reported side effects and contraindications) a
aAlternatively, for travel to rural areas with low risk of malaria infection, mosquito bite prevention can be combined with stand–by emergency treatment (SBET).
WHO Country List footnote: When available, the date of the most recent update or confirmation is indicated in parentheses in the country list. If no date is indicated, the most recent update or confirmation was provided before 2013.
CDC—Health Information for International Travel (current online edition)Areas with malaria: All.
- Drug resistance3 : Chloroquine.
- Malaria species: P. falciparum >85%, P. ovale 5%–10%, P. vivax rare.
- Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine.4
3 Refers to P. falciparum malaria unless otherwise noted.
4 Primaquine and tafenoquine can cause hemolytic anemia in people with G6PD deficiency. Patients must be screened for G6PD deficiency before starting primaquine or tafenoquine. See Tafenoquine Approved for Malaria Prophylaxis and Treatment for more information.
See also: Library article for Travelers' Diarrhea
High risk exists throughout the country, including in deluxe accommodations. Food and beverage precautions may reduce the likelihood of illness.
Travelers should carry loperamide for self-treatment of diarrhea and, if risk is moderate to high, an antibiotic to add if diarrhea is severe. Consult a knowledgeable health care provider regarding which antibiotic is appropriate for you and most effective for your destination.
Other Food-Borne Illnesses
Precautions to prevent seafood poisoning may be needed.
Insect- and Arthropod-Borne Diseases
African trypanosomiasis, chikungunya, dengue, leishmaniasis, onchocerciasis, West Nile virus, Zika may pose a risk. Personal protective measures are important.
Other Disease and Health Risks
Additional concerns include anthrax disease, Crimean-Congo hemorrhagic fever, helminths, hepatitis C, lassa fever, Marburg virus disease, marine hazards, schistosomiasis, sexually transmitted infections, snakebites, tuberculosis.
The material below includes information from the US Department of State (DOS), the UK Foreign, Commonwealth & Development Office (FCO), Global Affairs Canada (GAC), and Australia's Department of Foreign Affairs and Trade (DFAT), as well as from additional open-source material. Standard safety precautions that apply to all international travel can be found in the Library article Safety and Security.
Consular Travel Advice
Due to violent crime and ongoing security concerns, Australia (DFAT) advises avoiding travel to areas bordering Mali, and Australia (DFAT) advises reconsidering travel (or avoiding nonessential travel) to areas bordering Côte d'Ivoire, Liberia, and Sierra Leone. US (DOS), UK (FCO), and Canada (GAC) have no current warnings.
Low risk of attack by transnational terrorist groups exists throughout the country. Targets may include public places and events, including those frequented by tourists; and transportation systems.
High risk of violent crime (armed robbery, home invasion, carjacking, and assault) exists throughout the country, especially in Conakry and surrounding areas.
High risk of petty crime exists throughout the country, especially in Conakry (Madina, Niger, and Taouyah markets) and at airports, hotels, and restaurants.
Scams involving gems, precious metals, and false identity (such as criminals posing as military officers) have been reported.
Protests and demonstrations frequently occur throughout the country, especially in Conakry and other towns, and have the potential to turn violent without warning. Bystanders are at risk of harm from violence or from the response by authorities. Disruption to transportation, free movement, or the ability to carry out daily activities may occur.
A dangerous security environment and military presence may exist in border areas. Ethnic tensions may be present in Nzérékoré Region.
Significant risk of traffic-related injury or death exists. The road traffic death rate is more than 24 per 100,000 population, the highest risk category. Carefully assess the safety of transportation options before any road travel.
Speed laws are poorly enforced.
Seat belt laws are poorly enforced.
Drunk driving laws are poorly enforced.
Structural standards for vehicles may not meet international standards.
The rainy season is from May through October. Floods, mudslides, and landslides may occur.
Selected Embassies or Consulates in Guinea
- United States: [+224] 65-104-000; gn.usembassy.gov
- Canada: Canada does not have an embassy or consulate in Guinea.
- United Kingdom: [+224] 626-26-4040; www.gov.uk/world/organisations/british-embassy-conakry
- Australia: Australia does not have an embassy or consulate in Guinea.
Guinea's Embassies or Consulates in Selected Countries
- In the U.S.: guineaembassyusa.org
- In Canada: [+1] 613-789-8444
- In the U.K.: [+44] 020-7258-9640/46
- In Australia: Guinea does not have an embassy or consulate in Australia.
HIV testing is not required to obtain a tourist, work, or residence visa.